Summit Securities Group’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-74
| Closed | -$1.1K | – | 1262 |
|
|
2025
Q1 | $1.1K | Buy |
+74
| New | +$1.1K | ﹤0.01% | 562 |
|
|
2023
Q4 | – | Sell |
-5
| Closed | – | – | 697 |
|
|
2023
Q3 | $0 | Sell |
5
-895
| -99% | – | ﹤0.01% | 821 |
|
|
2023
Q2 | $14K | Hold |
900
| – | – | ﹤0.01% | 600 |
|
|
2023
Q1 | $15K | Sell |
900
-3,325
| -79% | -$55.4K | ﹤0.01% | 527 |
|
|
2022
Q4 | $66K | Buy |
4,225
+1,625
| +63% | +$25.4K | ﹤0.01% | 458 |
|
|
2022
Q3 | $34K | Sell |
2,600
-100
| -4% | -$1.31K | ﹤0.01% | 468 |
|
|
2022
Q2 | $38K | Sell |
2,700
-1,500
| -36% | -$21.1K | ﹤0.01% | 445 |
|
|
2022
Q1 | $60K | Sell |
4,200
-10,400
| -71% | -$149K | 0.01% | 377 |
|
|
2021
Q4 | $199K | Sell |
14,600
-9,500
| -39% | -$129K | 0.01% | 332 |
|
|
2021
Q3 | $395K | Sell |
24,100
-30,500
| -56% | -$500K | 0.03% | 210 |
|
|
2021
Q2 | $919K | Sell |
54,600
-19,477
| -26% | -$328K | 0.08% | 123 |
|
|
2021
Q1 | $1.35M | Buy |
+74,077
| New | +$1.35M | 0.15% | 67 |
|
|
2020
Q4 | – | Sell |
-15,086
| Closed | -$269K | – | 340 |
|
|
2020
Q3 | $269K | Buy |
+15,086
| New | +$269K | 0.03% | 120 |
|
|
2020
Q2 | – | Sell |
-254,651
| Closed | -$3.87M | – | 227 |
|
|
2020
Q1 | $3.87M | Buy |
+254,651
| New | +$3.87M | 0.68% | 13 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 286 |
|
|
2019
Q3 | – | Sell |
-22,802
| Closed | -$404K | – | 217 |
|
|
2019
Q2 | $404K | Buy |
+22,802
| New | +$404K | 0.05% | 84 |
|